Postherpetic Neuralgia (PHN) is an inflammatory neuropathic pain condition characterized by pain persisting for more than 30 days after the onset of the herpes zoster rash caused by a byproduct of varicella zoster virus reactivation. Symptoms include dysethesia, spontaneous burning pain; shooting, tic-like pain. PHN treatment guidelines recommend antiepileptic drugs (namely, Lyrica and gabapentin), followed by tricyclic antidepressants (e.g., amitriptyline), and topical lidocaine patches (e.g., the 5% lidocaine patch). Given the substantial percentage of patients with inadequate pain relief, together it is important to understand use of current therapies in newly diagnosed and recently treated PHN patients thought the use of national patient-level claims data.
Treatment Algorithms: Claims Data Analysis: Provides detailed analysis of brand usage across different lines of therapy using real-world data patient-level claims data so you can accurately assess your source of business and quantify areas of opportunity for increasing your brand share.